Cargando…
High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study
INTRODUCTION: Studies suggest that patients with cancer are more likely to experience severe outcomes from COVID-19. Therefore, cancer centres have undertaken efforts to care for patients with cancer in COVID-free units. Nevertheless, the frequency and relevance of nosocomial transmission of COVID-1...
Autores principales: | Elkrief, Arielle, Desilets, Antoine, Papneja, Neha, Cvetkovic, Lena, Groleau, Catherine, Lakehal, Yahia Abdelali, Shbat, Layla, Richard, Corentin, Malo, Julie, Belkaid, Wiam, Cook, Erin, Doucet, Stéphane, Tran, Thai Hoa, Jao, Kevin, Daaboul, Nathalie, Bhang, Eric, Loree, Jonathan M., Miller, Wilson H., Vinh, Donald C., Bouganim, Nathaniel, Batist, Gerald, Letendre, Caroline, Routy, Bertrand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470707/ https://www.ncbi.nlm.nih.gov/pubmed/33035991 http://dx.doi.org/10.1016/j.ejca.2020.08.017 |
Ejemplares similares
-
Characterization and description of Gabonibacter chumensis sp. nov., isolated from feces of a patient with non-small cell lung cancer treated with immunotherapy
por: Diop, Khoudia, et al.
Publicado: (2023) -
Incidence of thrombotic outcomes for patients hospitalized and discharged after COVID-19 infection
por: Bourguignon, Alex, et al.
Publicado: (2020) -
The intimate relationship between gut microbiota and cancer immunotherapy
por: Elkrief, Arielle, et al.
Publicado: (2018) -
Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study
por: Yolchuyeva, Sevinj, et al.
Publicado: (2023) -
Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers
por: Medjebar, Soleine, et al.
Publicado: (2020)